Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1878 1
1896 1
1898 1
1900 2
1902 1
1948 1
1951 3
1953 1
1954 2
1956 1
1957 1
1960 2
1963 1
1965 2
1966 1
1968 1
1969 1
1970 1
1971 1
1972 1
1973 1
1974 1
1975 2
1976 4
1978 2
1979 2
1981 1
1983 3
1984 2
1986 1
1987 1
1988 1
1989 1
1990 1
1992 2
1993 1
1994 1
1997 1
1999 1
2000 1
2001 1
2002 1
2003 6
2004 1
2005 3
2006 1
2007 4
2008 10
2009 5
2010 9
2011 7
2012 3
2013 5
2014 7
2015 6
2016 7
2017 4
2018 5
2019 6
2020 6
2021 4
2022 2
2023 8
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

151 results

Results by year

Filters applied: . Clear all
Page 1
DNA Sequencing to Detect Residual Disease in Adults With Acute Myeloid Leukemia Prior to Hematopoietic Cell Transplant.
Dillon LW, Gui G, Page KM, Ravindra N, Wong ZC, Andrew G, Mukherjee D, Zeger SL, El Chaer F, Spellman S, Howard A, Chen K, Auletta J, Devine SM, Jimenez Jimenez AM, De Lima MJG, Litzow MR, Kebriaei P, Saber W, Weisdorf DJ, Hourigan CS. Dillon LW, et al. Among authors: andrew g. JAMA. 2023 Mar 7;329(9):745-755. doi: 10.1001/jama.2023.1363. JAMA. 2023. PMID: 36881031 Free PMC article.
Canceroderms.
Andrew G. Andrew G. Glasgow Med J. 1902 Oct;58(4):264-266. Glasgow Med J. 1902. PMID: 30435680 Free PMC article. No abstract available.
Posttransplant MRD and T-cell chimerism status predict outcomes in patients who received allografts for AML/MDS.
Loke J, McCarthy N, Jackson A, Siddique S, Hodgkinson A, Mason J, Crawley C, Gilleece M, Peniket A, Protheroe R, Salim R, Tholouli E, Wilson K, Andrew G, Dillon R, Khan N, Potter V, Krishnamurthy P, Craddock C, Freeman S. Loke J, et al. Among authors: andrew g. Blood Adv. 2023 Jul 25;7(14):3666-3676. doi: 10.1182/bloodadvances.2022009493. Blood Adv. 2023. PMID: 37058448 Free PMC article.
Measurable Residual IDH1 before Allogeneic Transplant for Acute Myeloid Leukemia.
Gui G, Dillon LW, Ravindra N, Hegde PS, Andrew G, Mukherjee D, Wong Z, Auletta J, El Chaer F, Chen E, Chen YB, Corner A, Devine SM, Iyer S, Jimenez Jimenez AM, De Lima MJG, Litzow MR, Kebriaei P, Spellman SR, Zeger SL, Page KM, Hourigan CS. Gui G, et al. Among authors: andrew g. medRxiv [Preprint]. 2023 Aug 1:2023.07.28.23293166. doi: 10.1101/2023.07.28.23293166. medRxiv. 2023. PMID: 37577695 Free PMC article. Preprint.
Dentigerous Cysts.
Andrew G. Andrew G. Glasgow Med J. 1898 Aug;50(2):127-131. Glasgow Med J. 1898. PMID: 30436614 Free PMC article. No abstract available.
Fractionated vs single-dose gemtuzumab ozogamicin with determinants of benefit in older patients with AML: the UK NCRI AML18 trial.
Freeman SD, Thomas A, Thomas I, Hills RK, Vyas P, Gilkes A, Metzner M, Jakobsen NA, Kennedy A, Moore R, Almuina NM, Burns S, King S, Andrew G, Gallagher KME, Sellar RS, Cahalin P, Weber D, Dennis M, Mehta P, Knapper S, Russell NH. Freeman SD, et al. Among authors: andrew g. Blood. 2023 Nov 16;142(20):1697-1707. doi: 10.1182/blood.2023020630. Blood. 2023. PMID: 37595359 Free PMC article.
151 results